The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice

Scandinavian Journal of Immunology

Volumn 67, Issue 5, 2008, Pages 431-440

  Nystrom Asklin J ^a   Adamsson, J ^a   Harandi, A M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; CD4 ANTIGEN; CHEMOKINE; CHOLERA TOXIN B SUBUNIT; CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE CONJUGATED CHOLERA TOXIN B SUBUNIT; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; IMMUNOLOGICAL ADJUVANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CERVICAL LYMPH NODE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPEATED DRUG DOSE; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHOLERA TOXIN; CPG ISLANDS; CYTOKINES; FEMALE; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPH NODES; MESENTERY; MICE; MICE, INBRED C57BL; NECK; OLIGODEOXYRIBONUCLEOTIDES;

EID: 42049084684     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02085.x     Document Type: Article

References (48)

1. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981 292 : 413 7.
2. Raghavan S, Hjulstrom M, Holmgren J, Svennerholm AM. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect Immun 2002 70 : 6383 8.
3. Sutton P, Wilson J, Lee A. Further development of the Helicobacter pylori mouse vaccination model. Vaccine 2000 18 : 2677 85.
4. Sabirov A, Kodama S, Sabirova N, Mogi G, Suzuki M. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae. Vaccine 2004 22 : 3112 21.
5. Holmgren J, Lycke N, Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 1993 11 : 1179 84.
6. de Haan L, Hirst TR. Cholera toxin and related enterotoxins: a cell biological and immunological perspective. J Nat Toxins 2000 9 : 281 97.
7. Holmgren J, Harandi AM, Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev Vaccines 2003 2 : 205 17.
8. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002 20 : 709 60.
9. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 : 740 5.
10. Wagner H. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr Opin Immunol 2002 5 : 62 9.
11. Harandi AM, Holmgren J. CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections. Curr Opin Investig Drugs 2004 5 : 141 5.
12. Adamsson J, Lindblad M, Lundqvist A et al. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin. J Immunol 2006 176 : 4902 13.
13. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990 161 : 626 33.
14. Ermak TH, Giannasca PJ, Nichols R et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998 188 : 2277 88.
15. Garhart CA, Redline RW, Nedrud JG, Czinn SJ. Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect Immun 2002 70 : 3529 38.
16. Pappo J, Torrey D, Castriotta L et al. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 1999 67 : 337 41.
17. Raghavan S, Svennerholm AM, Holmgren J. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect Immun 2002 70 : 4621 7.
18. Sutton P, Danon SJ, Walker M et al. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 2001 49 : 467 73.
19. Nystrom J, Raghavan S, Svennerholm AM. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 2006 8 : 442 9.
20. Blanchard TG, Lycke N, Czinn SJ, Nedrud JG. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis. Immunology 1998 94 : 22 7.
21. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004 4 : 699 710.
22. Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect Immun 2000 68 : 969 72.
23. Park EJ, Chang JH, Kim JS, Yum JS, Chung SI. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes. Exp Mol Med 2000 32 : 72 8.
24. Shi T, Liu WZ, Gao F, Shi GY, Xiao SD. Intranasal CpG- oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Helicobacter 2005 10 : 71 9.
25. Lucas B, Bumann D, Walduck A et al. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling. Infect Immun 2001 69 : 1714 21.
26. Akhiani AA, Pappo J, Kabok Z et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 2002 169 : 6977 84.
27. Akhiani AA, Schon K, Lycke N. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice. J Immunol 2004 173 : 3348 56.
28. Raghavan S, Nystrom J, Fredriksson M, Holmgren J, Harandi AM. Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection. Infect Immun 2003 71 : 7014 22.
29. Jiang W, Baker HJ, Smith BF. Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective. Infect Immun 2003 71 : 40 6.
30. Lee A, O'Rourke J, De Ungria MC et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997 112 : 1386 97.
31. Ghiara P, Rossi M, Marchetti M et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 1997 65 : 4996 5002.
32. Lindholm C, Osek J, Svennerholm AM. Quantification of conserved antigens in Helicobacter pylori during different culture conditions. Infect Immun 1997 65 : 5376 80.
33. Svennerholm A-M, Holmgren J. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbant assay (GM1-ELISA) procedure. Curr Microbiol 1978 1 : 19 23.
34. Mattsson A, Tinnert A, Hamlet A et al. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin Diagn Lab Immunol 1998 5 : 288 93.
35. Yun CH, Lundgren A, Azem J et al. Natural killer cells and Helicobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production. Infect Immun 2005 73 : 1482 90.
36. Martin RM, Brady JL, Lew AM. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods 1998 212 : 187 92.
37. Suri-Payer E, Kehn PJ, Cheever AW, Shevach EM. Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells. J Immunol 1996 157 : 1799 805.
38. Nystrom J, Raghavan S, Svennerholm AM. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes and infection/Institut Pasteur 2006 8 : 442 9.
39. Eriksson K, Fredriksson M, Nordstrom I, Holmgren J. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect Immun 2003 71 : 1740 7.
40. Sano K, Shirota H, Terui T, Hattori T, Tamura G. Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner. J Immunol 2003 170 : 2367 73.
41. Hiroi T, Iwatani K, Iijima H et al. Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively. Eur J Immunol 1998 28 : 3346 53.
42. Kleanthous H, Myers GA, Georgakopoulos KM et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 1998 66 : 2879 86.
43. Sagodira S, Iochmann S, Mevelec MN, Dimier-Poisson I, Bout D. Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses. Parasite Immunol 1999 21 : 507 16.
44. Johansson EL, Bergquist C, Edebo A, Johansson C, Svennerholm AM. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach. Vaccine 2004 22 : 984 90.
45. Johansson EL, Wassen L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001 69 : 7481 6.
46. Londono-Arcila P, Freeman D, Kleanthous H et al. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun 2002 70 : 5096 106.
47. Shirota H, Sano K, Hirasawa N et al. Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells. J Immunol 2001 167 : 66 74.
48. Shirota H, Sano K, Kikuchi T, Tamura G, Shirato K. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 2000 164 : 5575 82.